Sabadell Asset Management’s Amgen AMGN Stock Holding History

Sabadell Asset Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$1.11M	Buy	4,930 +674	+16%	+$156K	0.23%	76
2023 Q1	$1.08M	Buy	4,256 +1,459	+52%	+$358K	0.23%	80
2022 Q4	$763K	Hold	2,797	–	–	0.16%	99
2022 Q3	$654K	Sell	2,797 -3,869	-58%	-$938K	0.14%	100
2022 Q2	$1.64M	Hold	6,666	–	–	0.34%	64
2022 Q1	$1.68M	Buy	6,666 +447	+7%	+$103K	0.29%	79
2021 Q4	$1.44M	Buy	6,219 +315	+5%	+$66.5K	0.23%	85
2021 Q3	$1.26M	Buy	5,904 +434	+8%	+$99.9K	0.22%	86
2021 Q2	$1.33M	Buy	+5,470	New	+$1.35M	0.23%	84

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Sabadell Asset Management's AMGN Position: Q2 2023 in Review

Sabadell Asset Management increased its Amgen (AMGN) stake by 16% in Q2 2023, buying an estimated $156K and bringing the position to 4,930 shares worth $1.11M. The position accounts for 0.23% of the portfolio, ranked #76.

Sabadell Asset Management first reported a position in AMGN in Q2 2021 and has held it in 9 quarters since. The position peaked at $1.68M in Q1 2022. 2,391 funds tracked by Wall St. Rank hold AMGN as of Q2 2023.

Sabadell Asset Management held 4,930 shares of Amgen worth $1.11M as of Q2 2023.
Sabadell Asset Management bought 674 Amgen shares in Q2 2023, an estimated $156K.
Amgen made up 0.23% of Sabadell Asset Management's portfolio in Q2 2023, its #76 holding.
Sabadell Asset Management first reported a position in Amgen in Q2 2021 and has held it in 9 quarters since.
Sabadell Asset Management's Amgen position peaked at $1.68M in Q1 2022.
2,391 funds tracked by Wall St. Rank held Amgen as of Q2 2023.

Based on Sabadell Asset Management's 13F filing for Q2 2023, filed 23 Jan 2024.